Literature DB >> 3148063

Alterations of NAD and adenylyl dinucleotide metabolism in Chediak-Higashi syndrome fibroblasts.

J C Baker1, B N Ames.   

Abstract

Chediak-Higashi syndrome (CHS) cells have been previously observed to exhibit several of the same characteristics as those of xeroderma pigmentosum (XP) and xeroderma pigmentosum variants. Cultured CHS fibroblasts have been examined for altered responses in both depletion of NAD and elevation of diadenosine-5',5"'-tetraphosphate (Ap4A) following DNA damage since both responses have been reported as altered in XP cells and since Ap4A has been reported as absent from the platelets of CHS patients. Lowering of NAD following UV irradiation occurred in CHS cells in a manner similar to that of control and XP variant cells, but different from that of XP cells. CHS fibroblasts were not found to be deficient in Ap4A and exhibit basal levels very similar to those of control fibroblasts. No change in Ap4A pools were observed which correlated with cell growth, in contrast to previously published reports. Furthermore, while Ap4A levels are not elevated in XP cells, we observe an elevation of Ap4A pools in CHS cells which mimics the elevations observed in control and XP variant cells. We conclude that: (1) CHS cells more closely resemble control or XP variant cells than XP cells with regard to NAD lowering and Ap4A elevation following UV irradiation; (2) the photosensitivity exhibited by CHS cells is not due to general defects in the synthesis of poly(ADP-ribose) from NAD or in Ap4A metabolism; and (3) alteration of Ap4A pool size in CHS fibroblasts is inappropriate as a biochemical marker for CHS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148063     DOI: 10.1007/bf01800362

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  Pyridine nucleotide levels as a function of growth in normal and transformed 3T3 cells.

Authors:  E L Jacobson; M K Jacobson
Journal:  Arch Biochem Biophys       Date:  1976-08       Impact factor: 4.013

2.  The Chediak-Higashi syndrome: studies in four patients and a review of the literature.

Authors:  R S Blume; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

3.  DNA repair mechanisms in Chediak--Higashi syndrome cells.

Authors:  H Tanaka; T Ito; T Orii
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

4.  Defective poly(adenosine diphosphoribose) synthesis in xeroderma pigmentosum.

Authors:  N A Berger; G W Sikorski; S J Petzold; K K Kurohara
Journal:  Biochemistry       Date:  1980-01-22       Impact factor: 3.162

5.  Highly efficient induction of human platelet aggregation in heparinized platelet-rich plasma by diadenosine triphosphate (Ap3A).

Authors:  J Lüthje; J Baringer; A Ogilvie
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

6.  Drastic rise of intracellular adenosine(5')tetraphospho(5')adenosine correlates with onset of DNA synthesis in eukaryotic cells.

Authors:  C Weinmann-Dorsch; A Hedl; I Grummt; W Albert; F J Ferdinand; R R Friis; G Pierron; W Moll; F Grummt
Journal:  Eur J Biochem       Date:  1984-01-02

7.  Alterations in levels of 5'-adenyl dinucleotides following DNA damage in normal human fibroblasts and fibroblasts derived from patients with xeroderma pigmentosum.

Authors:  J C Baker; B N Ames
Journal:  Mutat Res       Date:  1988-06       Impact factor: 2.433

8.  Diadenosine 5',5'''-p1,p4-tetraphosphate deficiency in blood platelets of the Chédiak-Higashi syndrome.

Authors:  B K Kim; F C Chao; R Leavitt; A S Fauci; K M Meyers; P C Zamecnik
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

9.  The presence of diadenosine 5',5'''-P1,P3-triphosphate (Ap3A) in human platelets.

Authors:  J Lüthje; A Ogilvie
Journal:  Biochem Biophys Res Commun       Date:  1983-08-30       Impact factor: 3.575

10.  Alteration of adenyl dinucleotide metabolism by environmental stress.

Authors:  J C Baker; M K Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.